Archive for the ‘infectious disease’ Category
The journal Blood has retracted a 2010 paper over the objections of most of its authors, two of whom were found by their university to have used “fraudulent methods” to obtain the data.
We first reported on the case of Gerold Feuer last fall. The State University of New York (SUNY) Upstate Medical Center in Syracuse fired Feuer in 2010 after determining that he had misused state funds to enrich a company he had founded, HuMurine. A court agreed with many of the university’s claims, but ordered his reinstatement in 2012.
Meanwhile, as we noted last fall: Read the rest of this entry »
Zoonoses and Public Health has retracted a 2013 paper on bird flu in Myanmar because the authors had published the article previously in a different journal.
The article, “Risks of Avian Influenza (H5) in Duck Farms in the Ayeyarwaddy Delta Region, Myanmar,” was written by a group led by Alongkorn Amonsin, of the Department of Veterinary Public Health at Chulalongkorn University, in Bangkok, Thailand.
The Journal of Maternal-Fetal & Neonatal Medicine has retracted a 2012 paper by a group of pediatric gut researchers in Naples, Italy, who seemed to have had a visceral reaction to using their own words.
The paper, “Composition and roles of intestinal microbiota in children,” sought to
provide an update of the advantages of new-generation molecular diagnostics to study the diversity of intestinal microflora and to evaluate its alteration in human diseases.
The agency’s director, David Wright, stepped down late last month for reasons that even now remain unclear. And in what seems to be an unrelated development, ORI has managed to draw the ire of Sen. Charles Grassley, who has been among the staunchest watchdogs over federal research integrity.
According to the Des Moines Register, the Iowa Republican
AAPS PharmSciTech, a journal of the American Association of Pharmaceutical Scientists, has retracted a 2013 paper by a group from India. The reason appears to be manipulated data, although the wording of the notice leaves that open to interpretation.
The article, “Design and Formulation Technique of a Novel Drug Delivery System for Azithromycin and Its Anti-Bacterial Activity Against Staphylococcus aureus,” was written by a trio of researchers at the Center for Nanobiotechnology at VIT University in Vellore.
In December, we reported on the case of Dong-Pyou Han, who was found by the Office of Research Integrity to have spiked rabbit blood samples to make it look as though a vaccine for HIV was working.
At the time, Han’s former institution, Iowa State, told us that “one oral presentation and some abstracts will be removed from the web.”
The paper, “Avian Reovirus Nonstructural Protein p17-Induced G2/M Cell Cycle Arrest and Host Cellular Protein Translation Shutoff Involve Activation of p53-Dependent Pathways,” came from a group at National Pingtung University of Science and Technology, in Pingtung, China. It purported to find that: Read the rest of this entry »
That must have been what happened to a quintet of authors from Shanghai who’ve just had to retract an article from the Journal of Antimicrobial Chemotherapy. Here’s the notice
(sadly, behind a paywall) [see note at end of post] for “Role of clofazimine in the treatment of multidrug-resistant tuberculosis: a retrospective observational cohort assessment:” Read the rest of this entry »